FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102542144> ?p ?o ?g. }

• W2102542144 endingPage "507" @default.
• W2102542144 startingPage "499" @default.
• W2102542144 abstract "Methylated DNA-binding protein 2 (MBD2) has been proposed to function both as a silencer of methylated genes and as a DNA demethylase. Our previous data indicated that knockdown of MBD2 inhibited tumourigenesis of human cancer lines and MBD2-deficient mice were recently shown to be resistant to intestinal tumourigenesis. MBD2 is an attractive anticancer target since MBD2-deficient mice were previously shown to be viable and fertile and knockdown of MBD2 was reported to have no effect on cellular growth parameters of non-transformed cells. In this paper we test the hypothesis that pharmacological inhibition of MBD2 inhibits cancer growth in vivo using human tumour lines implanted in mice as a model. We develop sequence-specific antisense inhibitors of MBD2 and we show that these agents inhibit anchorage-independent growth of human lung (A549) and colorectal (HCT116) cancer cell lines in vitro and tumourigenic growth of human cancer cell xenografts in vivo . MBD2 antisense oligonucleotide does not inhibit the growth of normal and transformed cell lines and does not alter cell cycle parameters in vitro and does not exhibit overt toxicity in vivo in comparison with a scrambled control oligonucleotide, as determined by measuring body mass, blood cell parameters and liver and kidney enzymes. Our data provide a proof of principle that MBD2 is a new anticancer target and that pharmacological inhibition of MBD2 by agents such as the antisense inhibitors described in this paper is a potential new anticancer therapy, which in contrast to the vast majority of current approaches does not target normal progression of the cell cycle." @default.
• W2102542144 created "2016-06-24" @default.
• W2102542144 creator A5043045350 @default.
• W2102542144 date "2003-10-24" @default.
• W2102542144 modified "2023-09-23" @default.
• W2102542144 title "Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo" @default.
• W2102542144 cites W130153342 @default.
• W2102542144 cites W1487964420 @default.
• W2102542144 cites W1524314479 @default.
• W2102542144 cites W1548506428 @default.
• W2102542144 cites W1552528612 @default.
• W2102542144 cites W1567517848 @default.
• W2102542144 cites W1605104953 @default.
• W2102542144 cites W1608490912 @default.
• W2102542144 cites W1637312052 @default.
• W2102542144 cites W1928891422 @default.
• W2102542144 cites W1973964951 @default.
• W2102542144 cites W1975227141 @default.
• W2102542144 cites W1978321192 @default.
• W2102542144 cites W1980711489 @default.
• W2102542144 cites W1988161295 @default.
• W2102542144 cites W1992368170 @default.
• W2102542144 cites W1992601419 @default.
• W2102542144 cites W2007287542 @default.
• W2102542144 cites W2010629311 @default.
• W2102542144 cites W2016287634 @default.
• W2102542144 cites W2016741645 @default.
• W2102542144 cites W2021621042 @default.
• W2102542144 cites W2030496627 @default.
• W2102542144 cites W2031129569 @default.
• W2102542144 cites W2035744678 @default.
• W2102542144 cites W2041420277 @default.
• W2102542144 cites W2042515987 @default.
• W2102542144 cites W2044798039 @default.
• W2102542144 cites W2045558184 @default.
• W2102542144 cites W2053468229 @default.
• W2102542144 cites W2060606238 @default.
• W2102542144 cites W2074496710 @default.
• W2102542144 cites W2075243610 @default.
• W2102542144 cites W2085297752 @default.
• W2102542144 cites W2090582597 @default.
• W2102542144 cites W2091196623 @default.
• W2102542144 cites W2149484379 @default.
• W2102542144 cites W2150515158 @default.
• W2102542144 cites W2151836161 @default.
• W2102542144 cites W2153900602 @default.
• W2102542144 cites W2161098391 @default.
• W2102542144 cites W2167376943 @default.
• W2102542144 cites W2171104778 @default.
• W2102542144 cites W2322277830 @default.
• W2102542144 doi "https://doi.org/10.1093/carcin/bgh045" @default.
• W2102542144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14688029" @default.
• W2102542144 hasPublicationYear "2003" @default.
• W2102542144 type Work @default.
• W2102542144 sameAs 2102542144 @default.
• W2102542144 citedByCount "65" @default.
• W2102542144 countsByYear W21025421442012 @default.
• W2102542144 countsByYear W21025421442013 @default.
• W2102542144 countsByYear W21025421442014 @default.
• W2102542144 countsByYear W21025421442015 @default.
• W2102542144 countsByYear W21025421442016 @default.
• W2102542144 countsByYear W21025421442017 @default.
• W2102542144 countsByYear W21025421442018 @default.
• W2102542144 countsByYear W21025421442019 @default.
• W2102542144 countsByYear W21025421442020 @default.
• W2102542144 countsByYear W21025421442021 @default.
• W2102542144 countsByYear W21025421442022 @default.
• W2102542144 countsByYear W21025421442023 @default.
• W2102542144 crossrefType "journal-article" @default.
• W2102542144 hasAuthorship W2102542144A5043045350 @default.
• W2102542144 hasBestOaLocation W21025421441 @default.
• W2102542144 hasConcept C121608353 @default.
• W2102542144 hasConcept C153911025 @default.
• W2102542144 hasConcept C173396325 @default.
• W2102542144 hasConcept C202751555 @default.
• W2102542144 hasConcept C207001950 @default.
• W2102542144 hasConcept C502942594 @default.
• W2102542144 hasConcept C54355233 @default.
• W2102542144 hasConcept C55493867 @default.
• W2102542144 hasConcept C555283112 @default.
• W2102542144 hasConcept C62112901 @default.
• W2102542144 hasConcept C81885089 @default.
• W2102542144 hasConcept C86803240 @default.
• W2102542144 hasConcept C95444343 @default.
• W2102542144 hasConcept C96232424 @default.
• W2102542144 hasConceptScore W2102542144C121608353 @default.
• W2102542144 hasConceptScore W2102542144C153911025 @default.
• W2102542144 hasConceptScore W2102542144C173396325 @default.
• W2102542144 hasConceptScore W2102542144C202751555 @default.
• W2102542144 hasConceptScore W2102542144C207001950 @default.
• W2102542144 hasConceptScore W2102542144C502942594 @default.
• W2102542144 hasConceptScore W2102542144C54355233 @default.
• W2102542144 hasConceptScore W2102542144C55493867 @default.
• W2102542144 hasConceptScore W2102542144C555283112 @default.
• W2102542144 hasConceptScore W2102542144C62112901 @default.
• W2102542144 hasConceptScore W2102542144C81885089 @default.
• W2102542144 hasConceptScore W2102542144C86803240 @default.
• W2102542144 hasConceptScore W2102542144C95444343 @default.

• next